We are live on ! Find out more
BCTXW

BriaCell Therapeutics Corp Warrant
BCTXW

Delisted

BCTXW was delisted on the 26th of February, 2026.

Back to rankings

7 hedge funds and large institutions have $15.1K invested in BriaCell Therapeutics Corp Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding

Funds holding: 4 → 7 (+3)

3.84% more ownership

Funds ownership: 1.26% → 5.11% (+3.8%)

88% less capital invested

Capital invested by funds: $129K → $15.1K (-$113K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$4.27K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25K
3
CS
Clear Street
New York
+$14

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$48.5K
2
UBS Group
UBS Group
Switzerland
-$516

BCTXW Hedge Fund Activity: Q1 2025 in Review

7 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q1 2025, worth a combined $15.1K — down 88% from $129K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BCTXW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $4.27K. The largest seller was Armistice Capital, cutting an estimated $48.5K.

  • 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q1 2025, up from 4 in Q4 2024.
  • Funds reported $15.1K of BriaCell Therapeutics Corp Warrant stock for Q1 2025, down 88% quarter-over-quarter.
  • 3 funds opened new BriaCell Therapeutics Corp Warrant positions in Q1 2025 and 0 closed out, a net change of +3 holders.
  • The largest BriaCell Therapeutics Corp Warrant buyer in Q1 2025 was Two Sigma Securities, an estimated $4.27K added.
  • The largest BriaCell Therapeutics Corp Warrant seller in Q1 2025 was Armistice Capital, an estimated $48.5K sold.

Based on aggregated 13F filings for Q1 2025.